The Compounding Pharmacy Market is being driven by Growing popularity of HRT fueling demand for compounded medications
The Compounding Pharmacy Market is expected to grow at a CAGR of 2.2% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1.74 billion. Compounding pharmacies, specialized in creating personalized medications, are experiencing significant growth due to their ability to facilitate early disease detection and precise treatment methods. This, in turn, contributes to a decrease in mortality rates. Advanced technologies, such as microarray, play a pivotal role in disease research by analyzing genomic variations and inherited syndromes linked to chronic conditions like cardiovascular diseases and cancer. The increasing recognition of genetic diseases drives the progression of compounding pharmacies, focusing on targeted drug development, to cater to the unique genetic makeup of individuals and improve overall health outcomes.
Get more information on Compounding Pharmacy Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
199 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 2.2% |
Market growth 2025-2029 |
USD 1.74 billion |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
2.1 |
Key countries |
US, Canada, France, China, India, Germany, Japan, UK, South Korea, BrazilUAE, US, Canada, France, China, India, Germany, Japan, UK, South Korea, and Brazil |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Compounding Pharmacy Market encompasses various product offerings, including Oral Suspensions, Topical Creams, IV Solutions, Hormone Replacement Therapy, Pain Management, Anti-Inflammatory Medications, Dermatological Medications, Oncology Medications, Veterinary Medications, Allergy Medications, Opioid Management, Biosimilar Medications, Precision Medicine, Genetic Testing, Drug Delivery Systems, 3D Printing, Artificial Intelligence, Big Data Analytics, Electronic Health Records, Patient Portals, Mobile Health Apps, Medication Adherence Programs, Patient Support Services, Clinical Pharmacy Services, Pharmacoeconomic Analysis, Cost-Effectiveness Analysis, Value-Based Healthcare, Pharmaceutical Industry Regulations, FDA Guidance, Compounding Pharmacy Laws, Professional Development, and Continuing Education. These products and services cater to diverse therapeutic areas, such as pain management, hormone replacement therapy, dermatology, oncology, veterinary medicine, allergy treatment, opioid management, and more. The market is witnessing significant growth due to the increasing demand for personalized medication solutions, regulatory support, and technological advancements in various areas, including precision medicine, genetic testing, drug delivery systems, and electronic health records.
The compounding pharmacy market is a niche segment within the larger global pharmaceuticals industry, focusing on the custom production of prescription medications in various dosage forms, including sterile and non-sterile compounding. This sector caters to unique patient requirements, beyond the scope of mass-produced, generic drugs. The market's growth is driven by several factors, such as the increasing global population aging, with the proportion of individuals over 60 years projected to rise significantly in developed markets like the US and Europe by 2030-2050. This demographic shift will lead to a higher demand for personalized, customized medications, thereby fueling the expansion of the compounding pharmacy market within the broader pharmaceuticals industry.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted